|
About Mechanisms in
Chronic Myelogenous Leukemia
Mechanisms in Chronic Myelogenous Leukemia
is an online CME resource, with content developed by an expert, multidisciplinary panel of specialists.
The content on this Website is intended for medical oncologists, hematologists, stem cell transplant physicians, and other interested healthcare professionals who manage and treat with chronic myelogenous leukemia in the hematology/oncology setting.
The purpose of this Website is to provide an e-learning resource about the mechanisms in chronic myelogenous leukemia. Each comprehensive learning module includes:
- Text, authored by leading experts in the treatment and management of chronic myelogenous leukemia
- Slide presentations
- Clinical case studies
- Medical animations
- Physician self-evaluation questionnaires
Click here to view the Learning Objectives for this educational Website.
|
Content Highlights
Chronic myelogenous
leukemia is a myelo-
proliferative disease
characterized by the
presence of a specific
cytogenetic abnormality,
the Philadelphia chromo-
some, which is the result
of a reciprocal trans-
location, t(9;22)(q34;q11),
between the long arms of
chromosomes 9 and 22
|
|
Editors-in-Chief
Dr Hagop Kantarjian
Editorial Faculty
Dr Jorge Cortes
Dr Michael Deininger
Dr Andreas Hochhaus
Dr Elias Jabbour
Dr Michael Mauro
Dr Susan O'Brien
Dr Giuseppe Saglio
|
This educational activity was made possible through an unrestricted educational grant from:
|